Farallon Capital Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $122K | Hold |
|
|||||
|
2025
Q1 | $102K | Hold |
|
|||||
|
2024
Q4 | $133K | Hold |
|
|||||
|
2024
Q3 | $184K | Sell |
|
|||||
|
2024
Q2 | $3.58M | Sell |
|
|||||
|
2024
Q1 | $3.1M | Buy |
|
|||||
|
2023
Q4 | $100K | Hold |
|
|||||
|
2023
Q3 | $166K | Sell |
|
|||||
|
2023
Q2 | $11.6M | Hold |
|
|||||
|
2023
Q1 | $10.6M | Buy |
|
|||||
|
2022
Q4 | $984K | Sell |
|
|||||
|
2022
Q3 | $3.66M | Sell |
|
|||||
|
2022
Q2 | $9.02M | Buy |
|
|||||
|
2022
Q1 | $6.37M | Buy |
|
|||||
|
2021
Q4 | $5.15M | Hold |
|
|||||
|
2021
Q3 | $5.05M | Hold |
|
|||||
|
2021
Q2 | $4.87M | Hold |
|
|||||
|
2021
Q1 | $5.27M | Hold |
|
|||||
|
2020
Q4 | $6.74M | Buy |
|